The nitric oxide redox sibling nitroxyl partially circumvents impairment of platelet nitric oxide responsiveness

Rustem Dautov, Doan Ngo, G Licari, Shen Liu, Aaron Sverdlov, R Ritchie, B Kemp-Harper, John Horowitz, Yuliy chirkov

    Research output: Contribution to journalArticlepeer-review

    22 Citations (Scopus)


    Impaired platelet responsiveness to nitric oxide (NO resistance) is a common characteristic of many cardiovascular disease states and represents an independent risk factor for cardiac events and mortality. NO resistance reflects both scavenging of NO by superoxide (O2-), and impairment of the NO receptor, soluble guanylate cyclase (sGC). There is thus an urgent need for circumvention of NO resistance in order to improve clinical outcomes. Nitroxyl (HNO), like NO, produces vasodilator and anti-aggregatory effects, largely via sGC activation, but is not inactivated by O2-. We tested the hypothesis that HNO circumvents NO resistance in human platelets. In 57 subjects with or without ischemic heart disease, platelet responses to the HNO donor isopropylamine NONOate (IPA/NO) and the NO donor sodium nitroprusside (SNP) were compared. While SNP (10 μM) induced 29 ± 3% (p < 0.001) inhibition of platelet aggregation, IPA/NO (10 μM) caused 75 ± 4% inhibition (p < 0.001). In NO-resistant subjects (n = 28), the IPA/NO:SNP response ratio was markedly increased (p < 0.01), consistent with partial circumvention of NO resistance. Similarly, cGMP accumulation in platelets was greater (p < 0.001) with IPA/NO than with SNP stimulation. The NO scavenger carboxy-PTIO (CPTIO, 200 μM) inhibited SNP and IPA/NO responses by 92 ± 7% and 17 ± 4% respectively (p < 0.001 for differential inhibition), suggesting that effects of IPA/NO are only partially NO-mediated. ODQ (10 μM) inhibited IPA/NO responses by 36 ± 8% (p < 0.001), consistent with a contribution of sGC/haem to IPA/NO inhibition of aggregation. There was no significant relationship between whole blood ROS content and IPA/NO responses. Thus the HNO donor IPA/NO substantially circumvents platelet NO resistance while acting, at least partially, as a haem-mediated sGC activator.

    Original languageEnglish
    Pages (from-to)72-78
    Number of pages7
    Publication statusPublished - 2013


    • cGMP
    • Isopropylamine-NONOate
    • Nitric oxide
    • Nitroxyl
    • NO resistance
    • Platelet aggregation


    Dive into the research topics of 'The nitric oxide redox sibling nitroxyl partially circumvents impairment of platelet nitric oxide responsiveness'. Together they form a unique fingerprint.

    Cite this